Potent and selective activity of a combination of thymidine and 1843U89, afolate-based thymidylate synthase inhibitor, against Plasmodium falciparum

Unlike mammalian cells, malarial parasites are completely dependent on the de novo pyrimidine pathway and lack the enzymes to salvage preformed pyrimi dines. In the present study, first, it is shown that 1843U89, even without polyglutamylation, is a potent folate-based inhibitor of purified malarial parasite thymidylate synthase. The binding was noncompetitive with respect to methylenetetrahydrofolate, end 1843U89 had a K-i of 1 nM. The compound a lso had potent antimalarial activity in vitro. Plasmodium falciparum cells in culture were inhibited by 1843U89, with a 50% inhibitory concentration o f about 70 nM. The compound was effective against drug-sensitive as well as drug-resistant clones of P. falciparum. As predicted by the biochemistry o f the parasite, the potent inhibition of parasite proliferation by 1843U89 could not be reversed with 10 mu M thymidine. In contrast, in the presence of 10 mu M thymidine, mammalian cells were unaffected by 1843U89 even at co ncentrations as high as 0.1 mM, thus offering a selectivity window of more than 1,000-fold. On this basis, folate based thymidylate synthase inhibitor s may represent a powerful additional tool that can be used to combat drug- resistant malaria.